In patients with MTHFR depression , this approach can be harmful
There may be a brief period where weight loss pauses or slows as you titrate up on tirzepatide, but once you reach a therapeutic dose, weight loss typically resumes often exceeding what you experienced on semaglutide
Many people notice a difference within 24 to 72 hours
doi: 10.3109/17453679809117617 187 BartokBFiresteinGS
GLP-1 as a Gateway, Not a Threat GLP-1s are not the enemy
The exception is in the diabetes space, where we have seen a wider advancement in pen or multi-dose injector digital connectivity, as well as one or two products that utilize expensive syringe injection aid/assistance devices, such as the syringe injection assistance device for Betaseron, whereby the user loads the syringe onto a battery and motor operated injection assistance device to help with injection